NEW IMMUNOCYTOKINES FOR TREATMENT OF CANCER
The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment us...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
23.07.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
本发明涉及可用于治疗癌症的新型免疫细胞因子。这些融合蛋白包含(i)抗体或其抗原结合片段,与(ii)可裂解肽连接子及(iii)细胞因子或其功能片段融合。同时公开了使用所述免疫细胞因子的治疗方法。 |
---|---|
Bibliography: | Application Number: CN201980076617 |